On June 28, 2019, Agile Therapeutics, Inc. announced that Dr. Elizabeth Garner, M.D., M.P.H., the Company's Senior Vice President and Chief Medical Officer, has accepted an offer to pursue another career opportunity and will be departing the Company effective July 15, 2019. Dr. Garner is working with the Company on the transition plan and has committed to supporting the Company's efforts to seek approval of Twirla. Dr. Garner will serve as a consultant to the Company on an as needed basis for a monthly retainer through December 31, 2019 (which includes the Company's PDUFA (the Prescription Drug User Fee Act) goal date) in order to assist with, among other things, the Company's scheduled Advisory Committee Meeting on October 30, 2019.